Table 1:

Baseline Characteristics of Patients with and without Cirrhotic Cardiomyopathy (CCM) By the Original and Revised Definition

	Original CCM Definition		Revised CCM Definition
Demographic Variables	No CCM (N = 48)	CCM (N = 162)	No CCM (N = 146)	CCM (N = 64)
Age	56	60	58	60
MELD at Transplant	29	28	28	28
Male Gender	28 (58%)	97 (60%)	94 (64%)	31 (48%)
Race
White	47 (98%)	153 (94%)	141 (97%)	59 (92%)
Black	--------	6 (4%)	2 (1%)	4 (6%)
Other	1 (2%)	3 (2%)	3 (2%)	1 (2%)
Disease Etiology
Non-Alcoholic Fatty Liver Disease	8 (17%)	61 (38%)	45 (31%)	24 (38%)
Alcohol-Associated Liver Disease	12 (25%)	39 (24%)	40 (28%)	11 (17%)
Hepatitis C Viral Infection	13 (27%)	28 (17%)	27 (18%)	14 (22%)
Other Etiologies	15 (31%)	34 (21%)	34 (23%)	15 (23%)
Smoking Pre-Transplant	18 (38%)	64 (40%)	53 (36%)	29 (45%)
BMI > 30 Pre-Transplant	8 (17%)	79 (48%)	55 (38%)	30 (47%)
Hypertension	8 (17%)	27 (17%)	25 (17%)	10 (16%)
Diabetes	3 (6%)	29 (18%)	25 (17%)	7 (11%)
Pre-Transplant Statin Use	6 (12%)	37 (23%)	29 (20%)	14 (22%)
Pre-Transplant Antiplatelet Therapy	19 (40%)	71 (44%)	59 (40%)	31 (48%)
Pre-Transplant Beta Blocker Use	34 (71%)	105 (65%)	97 (66%)	42 (66%)
Pre-Transplant Aldosterone Antagonists	47 (98%)	133 (82%)	123 (83%)	57 (89%)
Echocardiographic Variables (median)	No CCM (N = 48)	CCM (N = 162)	No CCM (N = 146)	CCM (N = 64)
Septal e’ (n = 201)	9.8	8	8.5	7.2
Lateral e’ (n = 204)	12	11	12	9.1
Average E/e’ Ratio (n = 201)	8.9	9.1	8.5	11.9
Tricuspid Regurgitant Maximal Velocity (n=183)	2.5	2.5	2.4	2.8
Left Atrium Volume Index (n = 202)	33	28	26	38
Mitral Valve Deceleration Time (n = 209)	170	246	218	252
Ejection Fraction (n = 210)	66	66	65	67
E/A Ratio
E/A ≤ 0.8	------	36 (23%)	23 (16%)	13 (22%)
E/A 0.9–1.9	43 (90%)	110 (71%)	112 (77%)	41 (71%)
E/A ≥2	5 (10%)	9 (6%)	10 (7%)	4 (7%)